Mounjaro (tirzepatide) Injection

Mounjaro (tirzepatide) is a once-weekly injectable medication recently approved in the UK for weight management. It aids in weight loss and maintenance by regulating appetite, promoting a sense of fullness, and reducing food cravings. This, in turn, helps decrease food intake and body weight.

Additional Information:

• Ingredients: Tirzepatide
• Special Instructions: Administered once weekly via subcutaneous injection in the abdomen, thigh, or upper arm. The starting dose is typically 2.5 mg once weekly for 4 weeks, with potential increases based on individual response, up to a maximum of 15 mg once weekly.
• Patient Information Leaflet: Available inside the pack.

Go Back & Get Started